BioXcel Therapeutics, Inc.
BTAIQ
$0.05
$0.009.56%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.84M | 17.18M | 28.42M | 36.18M | 17.44M |
| Total Receivables | 82.00K | 216.00K | 233.00K | -- | 17.00K |
| Inventory | 483.00K | 500.00K | 722.00K | 459.00K | 506.00K |
| Prepaid Expenses | 3.07M | 3.95M | 4.03M | 5.69M | 5.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 12.22M | 12.07M | 11.29M | 2.08M | 2.14M |
| Total Current Assets | 28.70M | 33.91M | 44.69M | 44.40M | 25.24M |
|
|
|||||
| Total Current Assets | 28.70M | 33.91M | 44.69M | 44.40M | 25.24M |
| Net Property, Plant & Equipment | 99.00K | 117.00K | 231.00K | 389.00K | 546.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 28.80M | 34.03M | 44.92M | 44.79M | 25.79M |
|
|
|||||
| Total Accounts Payable | 18.78M | 16.25M | 14.70M | 16.28M | 16.69M |
| Total Accrued Expenses | 4.04M | 6.52M | 4.45M | 4.38M | 5.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 104.45M | 22.43M | 25.00M | 16.98M | 11.47M |
| Total Finance Division Other Current Liabilities | 9.88M | 9.80M | 9.78M | 162.00K | 108.00K |
| Total Other Current Liabilities | 9.88M | 9.80M | 9.78M | 162.00K | 108.00K |
| Total Current Liabilities | 137.15M | 54.99M | 53.93M | 37.80M | 33.38M |
|
|
|||||
| Total Current Liabilities | 137.15M | 54.99M | 53.93M | 37.80M | 33.38M |
| Long-Term Debt | -- | 77.86M | 84.66M | 92.30M | 97.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.11M | 6.72M | 1.79M | 3.61M | 2.61M |
| Total Liabilities | 144.26M | 139.57M | 140.38M | 133.71M | 133.46M |
|
|
|||||
| Common Stock & APIC | 632.04M | 627.24M | 624.63M | 618.63M | 568.97M |
| Retained Earnings | -747.50M | -732.79M | -720.09M | -707.55M | -676.64M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -115.46M | -105.54M | -95.46M | -88.92M | -107.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -115.46M | -105.54M | -95.46M | -88.92M | -107.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -115.46M | -105.54M | -95.46M | -88.92M | -107.67M |
|
|
|||||